- Home
- GLPI vs RPRX Comparison
GLPI vs RPRX Comparison
Compare GLPI & RPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLPI
- RPRX
- Stock Information
- Founded
- GLPI 2013
- RPRX 1996
- Country
- GLPI United States
- RPRX United States
- Employees
- GLPI N/A
- RPRX N/A
- Industry
- GLPI Real Estate Investment Trusts
- RPRX Biotechnology: Pharmaceutical Preparations
- Sector
- GLPI Real Estate
- RPRX Health Care
- Exchange
- GLPI Nasdaq
- RPRX Nasdaq
- Market Cap
- GLPI 14.0B
- RPRX 11.8B
- IPO Year
- GLPI N/A
- RPRX 2020
- Fundamental
- Price
- GLPI $49.19
- RPRX $25.70
- Analyst Decision
- GLPI Buy
- RPRX Strong Buy
- Analyst Count
- GLPI 17
- RPRX 6
- Target Price
- GLPI $51.91
- RPRX $41.67
- AVG Volume (30 Days)
- GLPI 1.3M
- RPRX 2.5M
- Earning Date
- GLPI 10-24-2024
- RPRX 11-06-2024
- Dividend Yield
- GLPI 6.18%
- RPRX 3.27%
- EPS Growth
- GLPI 4.90
- RPRX 518.56
- EPS
- GLPI 2.86
- RPRX 2.55
- Revenue
- GLPI $1,510,960,000.00
- RPRX $2,266,003,000.00
- Revenue This Year
- GLPI N/A
- RPRX $12.38
- Revenue Next Year
- GLPI $5.06
- RPRX $11.26
- P/E Ratio
- GLPI $17.19
- RPRX $10.06
- Revenue Growth
- GLPI 7.33
- RPRX N/A
- 52 Week Low
- GLPI $41.80
- RPRX $25.10
- 52 Week High
- GLPI $52.60
- RPRX $31.66
- Technical
- Relative Strength Index (RSI)
- GLPI 42.02
- RPRX 30.45
- Support Level
- GLPI $48.50
- RPRX $26.08
- Resistance Level
- GLPI $49.72
- RPRX $28.36
- Average True Range (ATR)
- GLPI 0.96
- RPRX 0.60
- MACD
- GLPI -0.12
- RPRX -0.13
- Stochastic Oscillator
- GLPI 24.92
- RPRX 18.40
About GLPI Gaming and Leisure Properties Inc.
Gaming and Leisure Properties Inc, or GLP, is a real estate investment property trust whose primary business consists of acquiring, financing, and owning real estate property to be leased to gaming operators in triple-net lease arrangements. The GLPI's portfolio consisted of interests in sixty one gaming and related facilities, the real property associated with thirty four gaming and related facilities operated by PENN, the real property associated with six gaming and related facilities operated by Caesars Entertainment Corporation.
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.